According to a new report, published by KBV research, The Global Surgical Planning Software Market size is expected to reach $142.6 Million by 2028, rising at a market growth of 6.5% CAGR during the forecast period.
The On-premise segment is showcasing a CAGR of 4.7% during (2022 - 2028). The on-premise software is often chosen as a one-time, ongoing licensing cost. Since they provide complete ownership and control, on-premise applications are seen as being more trustworthy and secure. The business will also be liable for paying for improvements, upkeep, and training.
The Hospitals segment is leading the Global Surgical Planning Software Market by End-use in 2021, thereby, achieving a market value of $79.7 Million by 2028. With the use of effective surgery planning software, hospitals and clinics may improve operational efficiency, automate patient communication, and provide patients with predictable and open perioperative care pathways. It is increasingly typical in advanced surgery to use techniques that take into account specific patient characteristics. Procedures may be optimized in a less intrusive method for the patient with a personalized strategy and prior preparation of the operation.
The Neurosurgery segment has shown the growth rate of 6.8% during (2022 - 2028). Due to the use of technology, neurosurgery has developed into the best and most advanced surgical area. In recent years, the main aspects of neurosurgery that has improved patient outcomes have been precision and security. Modern imaging methods reveal the precise intricacy of the brain's architecture. The sophisticated neurosurgical planning software, with its automated processes and user-friendly interfaces, may be helpful for both simple and complex surgical operations.
The North America market dominated the Global Surgical Planning Software Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $60.6 Million by 2028. The Europe market is exhibiting a CAGR of 6% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 7.4% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/surgical-planning-software-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic plc, Materialise NV, Brainlab AG, 3D Systems Corporation, Renishaw Plc., Johnson & Johnson (DePuy Synthes), Canon, Inc. (Canon Medical Systems Corporation), and General Electric (GE) Co. (GE Healthcare).
By Deployment
By End Use
By Application
By Geography
Companies Profiled
Unique Offerings 
